SUBSCRIBE
SUBSCRIBE

Amylyx Pharmaceuticals

NEWS
Business
BioSpace Movers & Shakers, Jan. 15
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers and Shakers.
January 14, 2021
 · 
5 min read
 · 
Alex Keown
Load More
JOBS
IN THE PRESS
Press Releases
Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial
December 8, 2025
 · 
7 min read
Press Releases
Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
November 7, 2025
 · 
15 min read
Press Releases
Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences - November 3, 2025
November 3, 2025
 · 
1 min read
Press Releases
Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
October 31, 2025
 · 
1 min read
Press Releases
Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock
September 10, 2025
 · 
4 min read
Press Releases
Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)
August 28, 2025
 · 
7 min read
Press Releases
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
August 26, 2025
 · 
1 min read
Press Releases
Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results
August 7, 2025
 · 
15 min read
Press Releases
Amylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025
July 31, 2025
 · 
1 min read
Press Releases
Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025
July 14, 2025
 · 
9 min read
Load More